Cargando…

Artemisia Extract Suppresses NLRP3 and AIM2 Inflammasome Activation by Inhibition of ASC Phosphorylation

Artemisia princeps var. orientalis (Asteraceae, A. princeps) is a well-known traditional medicinal herb used for treating various inflammatory disorders in Korea, Japan, China, and other Asian countries. In the present study, we investigated the effects of A. princeps extract (APO) on interleukin- (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwak, Su-Bin, Koppula, Sushruta, In, Eun-Jung, Sun, Xiao, Kim, Young-Kyu, Kim, Myong-Ki, Lee, Kwang-Ho, Kang, Tae-Bong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857320/ https://www.ncbi.nlm.nih.gov/pubmed/29686531 http://dx.doi.org/10.1155/2018/6054069

Ejemplares similares

Inhibitory Effect and Mechanism of Arctium lappa Extract on NLRP3 Inflammasome Activation
por: Kim, Young-Kyu, et al.
Publicado: (2018)

Tyrosine Dephosphorylation of ASC Modulates the Activation of the NLRP3 and AIM2 Inflammasomes
por: Mambwe, Bezaleel, et al.
Publicado: (2019)

BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination
por: Shim, Do-Wan, et al.
Publicado: (2017)

Pyk2 activates the NLRP3 inflammasome by directly phosphorylating ASC and contributes to inflammasome-dependent peritonitis
por: Chung, I-Che, et al.
Publicado: (2016)

The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2011)

Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC
por: Zhao, Jia, et al.
Publicado: (2023)

Prion Pathogenesis in the Absence of NLRP3/ASC Inflammasomes
por: Nuvolone, Mario, et al.
Publicado: (2015)

Ethanol extract of Chrysanthemum zawadskii inhibits the NLRP3 inflammasome by suppressing ASC oligomerization in macrophages
por: Jang, Ah-Ra, et al.
Publicado: (2023)

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2013)

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2013)

ASC deglutathionylation is a checkpoint for NLRP3 inflammasome activation
por: Li, Shuhang, et al.
Publicado: (2021)

The ASC Speck and NLRP3 Inflammasome Function Are Spatially and Temporally Distinct
por: Nagar, Abhinit, et al.
Publicado: (2021)

Suppression of Glucagon-Like Peptide-1 Release by Inhibition of Intestinal NLRP3 Inflammasome Activation in Asc(–/–) and Nlrp3(–/–) Mice
por: Chen, Yu, et al.
Publicado: (2019)

Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1
por: Zorman, Jernej, et al.
Publicado: (2016)

The Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review
por: Ciążyńska, Magdalena, et al.
Publicado: (2021)

Adenovirus VA RNAI Blocks ASC Oligomerization and Inhibits NLRP3 Inflammasome Activation
por: Darweesh, Mahmoud, et al.
Publicado: (2019)

What are NLRP3-ASC specks? an experimental progress of 22 years of inflammasome research
por: Nagar, Abhinit, et al.
Publicado: (2023)

Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout
por: Lee, Hye Eun, et al.
Publicado: (2016)

Correction: Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1
por: Zorman, Jernej, et al.
Publicado: (2016)

Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)

Structure, Activation and Regulation of NLRP3 and AIM2 Inflammasomes
por: Sharma, Meenakshi, et al.
Publicado: (2021)

AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC
por: Hornung, Veit, et al.
Publicado: (2009)

ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
por: Zheng, Ran, et al.
Publicado: (2023)

Inflammasome components ASC and AIM2 modulate the acute phase of biomaterial implant-induced foreign body responses
por: Christo, Susan N., et al.
Publicado: (2016)

NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
por: Akther, Mahbuba, et al.
Publicado: (2021)

Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation
por: Van Opdenbosch, Nina, et al.
Publicado: (2014)

Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome
por: Sun, Lingbin, et al.
Publicado: (2019)

The Inflammasome Activity of NLRP3 Is Independent of NEK7 in HEK293 Cells Co-Expressing ASC
por: Machtens, Dominik Alexander, et al.
Publicado: (2022)

TIGAR deficiency induces caspase-1-dependent trophoblasts pyroptosis through NLRP3-ASC inflammasome
por: Guo, Junjun, et al.
Publicado: (2023)

Qiqilian ameliorates vascular endothelial dysfunction by inhibiting NLRP3-ASC inflammasome activation in vivo and in vitro
por: Luo, Yuan, et al.
Publicado: (2023)

Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis
por: In, Eun-Jung, et al.
Publicado: (2018)

Distinct axial and lateral interactions within homologous filaments dictate the signaling specificity and order of the AIM2-ASC inflammasome
por: Matyszewski, Mariusz, et al.
Publicado: (2021)

Anti-Inflammatory Effect ofEmodin via Attenuation of NLRP3 Inflammasome Activation
por: Han, Ji-Won, et al.
Publicado: (2015)

Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome
por: Birnbaum, Yochai, et al.
Publicado: (2016)

Chalcone Derivatives From Abelmoschus manihot Seeds Restrain NLRP3 Inflammasome Assembly by Inhibiting ASC Oligomerization
por: Su, Jinsong, et al.
Publicado: (2022)

Oligomeric states of ASC specks regulate inflammatory responses by inflammasome in the extracellular space
por: Yu, Tae-Geun, et al.
Publicado: (2023)

Dual Role of Inflammasome Adaptor ASC in Cancer
por: Protti, Maria Pia, et al.
Publicado: (2020)

ASC nanobodies to counteract the consequences of inflammasome activation
por: Adriouch, Sahil, et al.
Publicado: (2022)

Sinapic Acid Controls Inflammation by Suppressing NLRP3 Inflammasome Activation
por: Lee, Eun Hye, et al.
Publicado: (2021)

Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome
por: Yang, Chul-Su, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_osheqqd786ut9kv2riprcsn4dn